Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Regulation of the G2/M transition by p53

Oncogene volume 20, pages 1803–1815 (2001)Cite this article

Abstract

p53 protects mammals from neoplasia by inducing apoptosis, DNA repair and cell cycle arrest in response to a variety of stresses. p53-dependent arrest of cells in the G1 phase of the cell cycle is an important component of the cellular response to stress. Here we review recent evidence that implicates p53 in controlling entry into mitosis when cells enter G2 with damaged DNA or when they are arrested in S phase due to depletion of the substrates required for DNA synthesis. Part of the mechanism by which p53 blocks cells at the G2 checkpoint involves inhibition of Cdc2, the cyclin-dependent kinase required to enter mitosis. Cdc2 is inhibited simultaneously by three transcriptional targets of p53, Gadd45, p21, and 14-3-3σ. Binding of Cdc2 to Cyclin B1 is required for its activity, and repression of the cyclin B1 gene by p53 also contributes to blocking entry into mitosis. p53 also represses the cdc2 gene, to help ensure that cells do not escape the initial block. Genotoxic stress also activates p53-independent pathways that inhibit Cdc2 activity, activation of the protein kinases Chk1 and Chk2 by the protein kinases Atm and Atr. Chk1 and Chk2 inhibit Cdc2 by inactivating Cdc25, the phosphatase that normally activates Cdc2. Chk1, Chk2, Atm and Atr also contribute to the activation of p53 in response to genotoxic stress and therefore play multiple roles. p53 induces transcription of the reprimo, B99, and mcg10 genes, all of which contribute to the arrest of cells in G2, but the mechanisms of cell cycle arrest by these genes is not known. Repression of the topoisomerase II gene by p53 helps to block entry into mitosis and strengthens the G2 arrest. In summary, multiple overlapping p53-dependent and p53-independent pathways regulate the G2/M transition in response to genotoxic stress.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR, Stark GR . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497

  • Anderson H, Roberge M . 1996 Cell Growth Differ. 7: 83–90

  • Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B, Levine AS . 1996 EMBO J. 15: 2236–2248

  • Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K . 1997 Cell 89: 1175–1184

  • Azzam EI, de Toledo SM, Pykett MJ, Nagasawa H, Little JB . 1997 Cell Growth Differ. 8: 1161–1169

  • Bates S, Ryan KM, Phillips AC, Vousden KH . 1998 Oncogene 17: 1691–1703

  • Blasina A, Price BD, Turenne GA, McGowan CH . 1999 Curr. Biol. 9: 1135–1138

  • Bomsztyk, Van Seuningen I, Suzuki H, Denisenko O, Ostrowski J . 1997 FEBS Lett. 403: 113–115

  • Booher RN, Holman PS, Fattaey A . 1997 J. Biol. Chem. 272: 22300–22306

  • Boulaire J, Fotedar A, Fotedar R . 2000 Pathol. Biol. (Paris) 48: 190–202

  • Budhram-Mahedeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS . 1999 J. Biol. Chem. 274: 15237–15244

  • Bunz F, Dutriaux A, Lengauer C, Walkman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501

  • Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD . 1998 Science 281: 1677–1679

  • Cayrol C, Knibiehler M, Ducommun B . 1998 Oncogene 16: 311–320

  • Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . 1999 Nature 401: 616–620

  • Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B . 2000 Genes Dev. 14: 1584–1588

  • Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, Roninson IB . 2000 Oncogene 19: 2165–2170

  • Chang TH, Ray FA, Thompson DA, Schlegel R . 1997 Oncogene 14: 2383–2393

  • Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, Zhang X, Annan RS, Lu Q, Faucette LF, Scott GF, Li X, Carr SA, Johnson RK, Winkler JD, Zhou BB . 1999 Oncogene 18: 4047–4054

  • Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD . 1999 Proc. Natl. Acad. Sci. USA 96: 13777–13782

  • Chen JJ, Reid CE, Band V, Androphy EJ . 1995 Science 269: 529–531

  • Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL, Friend SH . 1998 EMBO J. 17: 159–169

  • de Teledo SM, Azzam EI, Keng P, Laffrenier S, Little JB . 1998 Cell Growth Differ. 9: 887–896

  • DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM . 1988 Cell 54: 275–283

  • Draetta G, Eckstein J . 1997 Biochim. Biophys. Acta. 1332: M53–63

  • Dulic V, Stein GH, Far DF, Reed SI . 1998 Mol. Cell. Biol. 18: 546–557

  • Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA . 1996 Mol. Cell. Biol. 16: 3454–3464

  • Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ, O'Connor PM . 1995 Cancer Res. 55: 1649–1654

  • Farmer G, Friedlander P, Colgan J, Manley JL, Prives C . 1996 Nucleic Acids Res. 24: 4281–4288

  • Filatov L, Golubovskaya V, Hurt JC, Byrd LL, Phillips JM, Kaufmann WK . 1998 Oncogene 16: 1825–1838

  • Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA . 2000 Mol. Cell. Biol. 20: 4210–4223

  • Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF . 1996 Science 271: 1744–1747

  • Furnari B, Rhind N, Russell P . 1997 Science 277: 1495–1497

  • Gao Q, Srinivasan S, Boyer SN, Wazer DE, Band V . 1999 Mol. Cell. Biol. 19: 733–744

  • Ghosh S, Schroeter D, Paweletz N . 1996 Exp. Cell Res. 227: 165–169

  • Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, Piwnica-Worms H . 2000 J. Biol. Chem. 275: 5600–5605

  • Guadagno TM, Newport JW . 1996 Cell 84: 73–82

  • Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA . 1995 Oncogene 10: 2263–2270

  • Hagting A, Karlsson C, Clute P, Jackman M, Pines J . 1998 EMBO J. 17: 4127–4138

  • Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E . 1995 Mol. Biol. Cell 6: 387–400

  • Hartwell LH, Weinert TA . 1989 Science 246: 629–634

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell 1: 3–11

  • Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW . 2000 Science 287: 1824–1827

  • Hitomi M, Shu J, Agarwal M, Agarwal A, Stacey DW . 1998 Oncogene 17: 959–969

  • Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace Jr AJ . 1999 Nat. Genet. 23: 176–184

  • Hurford Jr RK Cobrinik D, Lee MH, Dyson N . 1997 Genes Dev. 11: 1447–1463

  • Imai T, Matsuda K, Shimojima T, Hashimoto T, Masuhiro Y, Kitamoto T, Sugita A, Suzuki K, Matsumoto H, Masushige S, Nogi Y, Muramatsu M, Handa H, Kato S . 1997 Biochem. Biophys. Res. Commun. 233: 765–769

  • Innocente SA, Abrahamson JL, Cogswell JP, Lee JM . 1999 Proc. Natl. Acad. Sci. USA 96: 2147–2152

  • Izumi T, Maller JL . 1993 Mol. Biol. Cell 4: 1337–1350

  • Jackson Jr, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A . 2000 Cancer Res. 60: 566–572

  • Jin P, Hardy S, Morgan DO . 1998 J. Cell Biol. 141: 875–885

  • Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace Jr AJ, Zhan Q . 2000 J. Biol. Chem. 275: 16602–16608

  • Kastan MB, Onyekwere Om, Sidransky D, Vogelstein B, Craig RW . 1991 Cancer Res. 51: 6304–6311

  • Kaufmann WK, Sxhwartz JL, Hurt JC, Byrd LL, Galloway DA, Levedakou E, Paules RS . 1997 Cell Growth Differ. 8: 1105–1114

  • Kiledjian M, Wang X, Liebhaber SA . 1995 EMBO J. 14: 4357–4364

  • Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616

  • Kumagai A, Dunphy WG . 1999 Genes Dev. 13: 1067–1072

  • Lakin ND, Jackson SP . 1999 Oncogene 18: 7644–7655

  • Lane DP, Crawford LV . 1979 Nature 278: 261–263

  • Leach SD, Scatena CD, Keefer CJ, Goodman HA, Song SY, Yang L, Pietenpol JA . 1998 Cancer Res. 58: 3231–3236

  • Leffers H, Madsen P, Rasmussen HH, Honore B, Andersen AH, Walbum E, Vandekerckhove J, Celis JE . 1993 J. Mol. Biol. 231: 982–998

  • Liu F, Stanton JJ, Wu Z, Piwnica-Worms H . 1997 Mol. Cell. Biol. 17: 571–583

  • Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ . 2000 Genes Dev. 14: 1448–1459

  • Lopez-Girona A, Furnari B, Mondesert O, Russell P . 1999 Nature 397: 172–175

  • Lu KP, Hunter T . 1995 Prog. Cell Cycle Res. 1: 187–205

  • Mack DH, Vartikar J, Pipas JM, Laimins LA . 1993 Nature 363: 281–283

  • Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ . 2000 Proc. Natl. Acad. Sci. USA 97: 10389–10394

  • McShea A, Samuel T, Eppel JT, Galloway DA, Funk JO . 2000 J. Biol. Chem. 275: 23181–23186

  • Medema RH, Klompmaker R, Smits VA, Rijksen G . 1998 Oncogene 16: 431–441

  • Michalovitz D, Halevy O, Oren M . 1990 Cell 62: 671–680

  • Michelotti EF, Michelotti GA, Aronsohn AI, Levens D . 1996 Mol. Cell. Biol. 16: 2350–2360

  • Moore JD, Yang J, Truant R, Kornbluth S . 1999 J. Cell Biol. 144: 213–224

  • Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, Reed SI . 1998 Cell. Biol. 18: 629–643

  • Nurse P . 1990 Nature 344: 503–508

  • Ohki R, Nemoto J, Murasawa H, Oda E, Inazawa J, Tanaka N, Taniguchi T . 2000 J. Biol. Chem. 275: 22627–22630

  • Ostareck DH, Ostareck-Lederer A, Wilm M, Thiele BJ, Mann M, Hentze MW . 1997 Cell 89: 597–606

  • Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY . 2000 Cancer Res. 60: 542–545

  • Parker LL, Piwnica-Worms H . 1992 Science 257: 1955–1957

  • Passalaris TM, Benanti JA, Gewin L, Kiyone T, Galloway DA . 1999 Mol. Cell. Biol. 19: 5872–5881

  • Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD, Galloway DA, Donehower LA, Tainsky MA, Kaufmann WK . 1995 Cancer Res. 55: 1763–1773

  • Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H . 1997 Science 277: 1501–1505

  • Pines J . 1995 Biochem. J. 308: 697–711

  • Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S . 1995 Cancer Res. 55: 1643–1648

  • Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y . 1993 Oncogene 8: 1183–1193

  • Rudolph NS, Latt SA . 1989 Mutat. Res. 211: 31–41

  • Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ . 1997 Science 277: 1497–1501

  • Sandri MI, Isaacs RJ, Ongkeko WM, Harris AL, Hickson ID, Broggini M, Vikhanskaya F . 1996 Nucleic Acids Res. 24: 4464–4470

  • Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT . 1999 Cancer Res. 59: 4375–4382

  • Schlegel R, Pardee AB . 1986 Science 232: 1264–1266

  • Schneider E, Montenarh M, Wagner P . 1998 Oncogene 17: 2733–2741

  • Schwartz D, Almog N, Peled A, Goldfinger N, Rotter V . 1997 Oncogene 15: 2597–2607

  • Shieh SY, Ahn J, Tamai K, Taya Y, Prives C . 2000 Genes Dev. 14: 289–300

  • Smith EJ, Leone G, De Gregori J, Jakoi L, Nevins JR . 1996 Mol. Cell. Biol. 16: 6965–6976

  • Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH . 2000 J. Biol. Chem. 275: 30638–30643

  • Spacey SD, Gatti RA, Bebb G . 2000 Can. J. Neurol. Sci. 27: 184–191

  • Steinmann KE, Belinsky GS, Lee D, Schlegel R . 1991 Proc. Natl. Acad. Sci. USA 88: 6843–6847

  • Stewart N, Hicks GG, Paraskevas F, Mowat M . 1995 Oncogene 10: 109–115

  • Sugarman JL, Schonthal AH, Glass CK . 1995 Mol. Cell. Biol. 15: 3282–3290

  • Takizawa CG, Weis K, Morgan DO . 1999 Proc. Natl. Acad. Sci. USA 96: 7938–7943

  • Tang HY, Zhao K, Pizzolato JF, Fonarev M, Langer JC, Manfredi JJ . 1998 J. Biol. Chem. 273: 29156–29163

  • Taylor WR, Agarwal ML, Agarwal A, Stacey DW, Stark GR . 1999a Oncogene 18: 283–295

  • Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS, Stark GR . 1999b Mol. Biol. Cell 10: 3607–3622

  • Taylor WR, Schonthal AH, Galante J, Stark GR . 2001 J. Biol. Chem. 276: 1998–2006

  • Thompson DA, Belinsky G, Chang TH, Jones DL, Schlegel R, Munger K . 1997 Oncogene 15: 3025–3035

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT . 1999 Genes Dev. 13: 152–157

  • Toczyski DP, Galgoczy DJ, Hartwell LH . 1997 Cell 90: 1097–1106

  • Tommasi S, Pfeifer GP . 1995 Mol. Cell. Biol. 15: 6901–6913

  • Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E . 1998 EMBO J. 17: 2728–2735

  • Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C . 1998 EMBO J. 17: 5015–5025

  • Vairo G, Livingston DM, Ginsberg D . 1995 Genes Dev. 9: 869–881

  • Waga S, Hannon GJ, Beach D, Stillman B . 1994 Nature 369: 574–578

  • Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O'Connor PM . 1996 J. Natl. Cancer Inst. 88: 956–965

  • Wang Q, Zambetti GP, Suttle DP . 1997 Mol. Cell. Biol. 17: 389–397

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci, USA 96: 3706–3711

  • Watanabe N, Broome M, Hunter T . 1995 EMBO J. 14: 1878–1891

  • Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ . 2000 Mol. Cell. Biol. 20: 5797–5807

  • Winters ZE, Ongkeko WM, Harris AL, Norbury CJ . 1998 Oncogene 17: 673–684

  • Withoff S, De Jong S, De Vries EG, Mulder NH . 1996 Anticancer Res. 16: 1867–1880

  • Yang J, Bardes ES, Moore JD, Brennan J, Powers MA, Kornbluth S . 1998 Genes Dev. 12: 2131–2143

  • Yoshida M, Usui T, Tsujimura K, Inagaki M, Beppu T, Horinouchi S . 1997 Exp. Cell Res. 232: 225–239

  • Yun J, Chae HD, Choy HE, Chung J, Yoo HS, Han MH, Shin DY . 1999 J. Biol. Chem. 274: 29677–29682

  • Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace Jr AJ . 1999 Oncogene 18: 2892–2900

  • Zheng N, Fraenkel E, Pabo CO, Pavletich NP . 1999 Genes Dev. 13: 666–674

  • Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD, Khanna KK . 2000 J. Biol. Chem. 275: 10342–10348

  • Zhu J, Chen X . 2000 Mol. Cell. Biol. 20: 5602–5618

  • Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K, Muller R . 1995 EMBO J. 14: 4514–4522

Download references

Acknowledgements

We are grateful to Dr Alan Eastman (Norris Cotton Cancer Center, Dartmouth Medical School) for sharing unpublished information. This work was supported by grant GM49345 from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Department of Molecular Biology, Lerner Research Insititute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA

    William R Taylor & George R Stark

Authors
  1. William R Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George R Stark
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, W., Stark, G. Regulation of the G2/M transition by p53. Oncogene 20, 1803–1815 (2001). https://doi.org/10.1038/sj.onc.1204252

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204252

Keywords

This article is cited by

Search

Advanced search

Quick links